<i>HER2</i> Amplification Level Predicts Pathological Complete Response in the Neoadjuvant Setting of HER2-Overexpressing Breast Cancer: A Meta-Analysis and Systematic Review

<i>HER2</i> Amplification Level Predicts Pathological Complete Response in the Neoadjuvant Setting of HER2-Overexpressing Breast Cancer: A Meta-Analysis and Systematic Review

Anti-HER2 therapies have dramatically improved the prognosis of human epidermal growth factor receptor 2 (HER2)-overexpressing cancers. However, the correlation between the <i>HER2</i> copy number and the response rate to anti-HER2 remains unclear. Here, following the PRISMA method, we p...

Full description

Bibliographic Details
Main Authors: Burak Gonullu, Eurydice Angeli, Frédéric Pamoukdjian, Guilhem Bousquet
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:International Journal of Molecular Sciences
Subjects:
<i>HER2</i> amplification
breast neoplasms
pCR
neoadjuvant therapy
anti-HER2 therapy
Online Access:https://www.mdpi.com/1422-0067/24/4/3590

Internet

https://www.mdpi.com/1422-0067/24/4/3590

Similar Items